STOCK TITAN

Escalade Financials

ESCA
FY2025 annual
Revenue $240.2M -4.5% YoY
Net Income $13.7M +5.5% YoY
EPS (Diluted) $0.99 +6.5% YoY
Free Cash Flow $28.5M -16.2% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Escalade (ESCA) reported $240.2M in revenue for fiscal year 2025, down 4.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ESCA FY2025

Cash release from shrinking working capital has funded debt reduction and shareholder payouts even as sales continued to soften.

From FY2022 to FY2025, inventory fell from $121.9M to $68.5M, releasing a large amount of cash that had been tied up in stock. Because FY2025 operating cash flow of $31.0M still exceeded net income of $13.7M, cash conversion was being helped by working-capital normalization, not just by stronger earnings.

Revenue kept slipping, yet gross margin widened from 23.4% to 26.9%, which points to better product economics rather than a simple volume rebound on a smaller sales base. At the same time, selling and administrative costs stayed near $44M, so the benefit did not fully turn into operating profit and suggests limited operating leverage.

The balance sheet is materially lighter: long-term debt fell from $43.8M to $11.3M over the recent period, while the debt-to-equity ratio shrank to 0.1x. With capital spending of only $2.5M, the business had room to keep paying dividends of $8.3M without depending on new borrowing.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 68 / 100
Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Escalade's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
67

Escalade has an operating margin of 7.8%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is down from 8.0% the prior year.

Growth
19

Escalade's revenue declined 4.5% year-over-year, from $251.5M to $240.2M. This contraction results in a growth score of 19/100.

Leverage
91

Escalade carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
87

With a current ratio of 4.28, Escalade holds $4.28 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 87/100.

Cash Flow
76

Escalade converts 11.9% of revenue into free cash flow ($28.5M). This strong cash generation earns a score of 76/100.

Returns
70

Escalade earns a strong 7.9% return on equity (ROE), meaning it generates $8 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 70/100. This is up from 7.7% the prior year.

Altman Z-Score Safe
6.54

Escalade scores 6.54, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($290.3M) relative to total liabilities ($48.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Escalade passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.26x

For every $1 of reported earnings, Escalade generates $2.26 in operating cash flow ($31.0M OCF vs $13.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
22.40x

Escalade earns $22.40 in operating income for every $1 of interest expense ($18.7M vs $836K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$240.2M
YoY-4.5%
5Y CAGR-2.6%
10Y CAGR+4.2%

Escalade generated $240.2M in revenue in fiscal year 2025. This represents a decrease of 4.5% from the prior year.

EBITDA
$23.8M
YoY-8.7%
5Y CAGR-8.5%
10Y CAGR+2.8%

Escalade's EBITDA was $23.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 8.7% from the prior year.

Net Income
$13.7M
YoY+5.5%
5Y CAGR-12.0%
10Y CAGR+1.7%

Escalade reported $13.7M in net income in fiscal year 2025. This represents an increase of 5.5% from the prior year.

EPS (Diluted)
$0.99
YoY+6.5%
5Y CAGR-11.5%
10Y CAGR+1.9%

Escalade earned $0.99 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$28.5M
YoY-16.2%
10Y CAGR+10.6%

Escalade generated $28.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 16.2% from the prior year.

Cash & Debt
$11.9M
YoY+183.2%
5Y CAGR+27.6%
10Y CAGR+19.6%

Escalade held $11.9M in cash against $11.3M in long-term debt as of fiscal year 2025.

Shares Outstanding
14M
YoY-0.3%
5Y CAGR-0.3%
10Y CAGR-0.3%

Escalade had 14M shares outstanding in fiscal year 2025. This represents a decrease of 0.3% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
26.9%
YoY+2.2pp
5Y CAGR-0.4pp
10Y CAGR-0.3pp

Escalade's gross margin was 26.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the prior year.

Operating Margin
7.8%
YoY-0.2pp
5Y CAGR-4.3pp
10Y CAGR-0.2pp

Escalade's operating margin was 7.8% in fiscal year 2025, reflecting core business profitability. This is down 0.2 percentage points from the prior year.

Net Margin
5.7%
YoY+0.5pp
5Y CAGR-3.8pp
10Y CAGR-1.6pp

Escalade's net profit margin was 5.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.5 percentage points from the prior year.

Return on Equity
7.9%
YoY+0.2pp
5Y CAGR-10.7pp
10Y CAGR-4.1pp

Escalade's ROE was 7.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the prior year.

Capital Allocation

R&D Spending
$3.2M
YoY0.0%
5Y CAGR+16.4%
10Y CAGR+7.9%

Escalade invested $3.2M in research and development in fiscal year 2025. That is unchanged from the prior year.

Share Buybacks
$3.1M
YoY+41.2%
5Y CAGR-14.4%

Escalade spent $3.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 41.2% from the prior year.

Capital Expenditures
$2.5M
YoY+23.3%
5Y CAGR-14.4%
10Y CAGR-6.8%

Escalade invested $2.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 23.3% from the prior year.

ESCA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ESCA annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$243.8M$240.2M-4.5%$251.5M-4.6%$263.6M-16.0%$313.8M0.0%$313.6M+14.6%$273.6M+51.6%$180.5M+2.7%$175.8M-0.9%$177.3M+3.3%$171.7M+7.7%$159.5M+0.4%$158.8M-3.0%$163.7M+10.9%$147.6M+9.9%$134.3M
Cost of Revenue$175.2M$175.5M-7.3%$189.3M-6.2%$201.8M-16.0%$240.1M+1.5%$236.5M+18.9%$198.8M+43.9%$138.2M+5.7%$130.8M-1.4%$132.6M+4.1%$127.4M+9.8%$116.0M+19.7%$96.9M+4.2%$93.0M+16.3%$79.9M-13.6%$92.5M
Gross Profit$68.7M$64.6M+3.9%$62.2M+0.7%$61.8M-16.1%$73.6M-4.5%$77.1M+3.1%$74.8M+76.6%$42.4M-5.9%$45.0M+0.7%$44.7M+1.0%$44.3M+1.8%$43.5M-29.8%$61.9M-12.4%$70.7M+4.5%$67.7M+62.2%$41.7M
R&D ExpensesN/A$3.2M0.0%$3.2M+3.2%$3.1M+14.8%$2.7M+35.0%$2.0M+33.3%$1.5M-6.3%$1.6M+6.7%$1.5M-6.3%$1.6M+6.7%$1.5M0.0%$1.5M-11.8%$1.7M+41.7%$1.2M+20.0%$1.0M-28.6%$1.4M
SG&A Expenses$46.0M$43.6M+0.7%$43.3M+4.4%$41.5M-7.3%$44.8M+3.2%$43.4M+7.6%$40.3M+27.5%$31.6M+6.1%$29.8M+4.4%$28.5M+4.4%$27.4M-1.5%$27.8M+21.1%$22.9M+6.9%$21.5M+16.3%$18.4M-48.7%$35.9M
Operating Income$30.2M$18.7M-6.4%$20.0M+12.3%$17.8M-32.3%$26.3M-17.5%$31.9M-3.4%$33.0M+256.1%$9.3M-32.9%$13.8M-5.4%$14.6M+0.1%$14.6M+13.8%$12.8M-17.3%$15.5M-4.2%$16.2M+34.4%$12.0M+188.8%$4.2M
Interest Expense$743K$836K-63.7%$2.3M-57.0%$5.3M+41.5%$3.8M+150.3%$1.5M+504.0%$250K-29.8%$356K-16.6%$427K-46.9%$804K-3.6%$834K+77.4%$470K+5.1%$447K+10.6%$404K+359.1%$88K-87.3%$693K
Income Tax$7.0M$4.3M-9.8%$4.8M+79.8%$2.7M-42.4%$4.6M-24.7%$6.1M-12.1%$7.0M+316.9%$1.7M-72.1%$6.0M+300.0%-$3.0M-174.1%$4.0M-0.5%$4.1M+1100.0%$339K-95.1%$6.9M+78.9%$3.8M+58.1%$2.4M
Net Income$23.1M$13.7M+5.5%$13.0M+32.1%$9.8M-45.4%$18.0M-26.3%$24.4M-5.9%$25.9M+257.3%$7.3M-64.5%$20.4M+45.4%$14.1M+22.3%$11.5M-1.0%$11.6M-1.8%$11.8M+20.5%$9.8M+298.9%-$4.9M-211.0%$4.4M
EPS (Diluted)$0.99+6.5%$0.93+31.0%$0.71-45.8%$1.31-25.6%$1.76-3.3%$1.82+264.0%$0.50-64.5%$1.41+43.9%$0.98+22.5%$0.80-2.4%$0.82-2.4%$0.84+16.7%$0.72+294.6%-$0.37-212.1%$0.33

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ESCA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ESCA annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$222.1M-1.9%$226.3M-10.5%$253.0M-15.3%$298.7M+18.6%$251.8M+14.1%$220.7M+48.3%$148.8M-0.5%$149.5M-4.2%$156.1M+3.5%$150.8M+4.9%$143.7M+12.4%$127.9M-9.9%$142.0M+12.9%$125.7M-3.4%$130.1M
Current Assets$130.6M-2.4%$133.8M-8.9%$146.8M-22.0%$188.2M+10.0%$171.1M+17.6%$145.4M+67.3%$86.9M-1.1%$87.9M+9.5%$80.3M+6.1%$75.6M+3.9%$72.8M+5.7%$68.9M-15.2%$81.2M+14.4%$71.0M+10.6%$64.1M
Cash & Equivalents$11.9M+183.2%$4.2M+26112.5%$16K-99.6%$4.0M-9.3%$4.4M+24.8%$3.5M-40.4%$5.9M+108.3%$2.8M+79.6%$1.6M+55.2%$1.0M-48.9%$2.0M-38.7%$3.2M+196.2%$1.1M-57.1%$2.5M-33.4%$3.8M
Inventory$68.5M-9.9%$76.0M-17.8%$92.5M-24.1%$121.9M+31.9%$92.4M+27.4%$72.5M+71.5%$42.3M+8.0%$39.1M+11.3%$35.2M+4.0%$33.8M+30.7%$25.9M+8.8%$23.8M+25.5%$18.9M-38.6%$30.9M+6.3%$29.0M
Accounts Receivable$46.3M-5.0%$48.8M-2.4%$50.0M-12.9%$57.4M-13.0%$66.0M+1.1%$65.3M+84.1%$35.5M-12.9%$40.7M+3.4%$39.4M+9.6%$35.9M-7.9%$39.0M+21.3%$32.1M-16.0%$38.3M+14.3%$33.5M+24.5%$26.9M
Goodwill$42.3M0.0%$42.3M0.0%$42.3M0.0%$42.3M+29.5%$32.7M0.0%$32.7M+22.2%$26.7M+1.4%$26.4M+22.4%$21.5M+0.4%$21.5M+7.0%$20.0M+34.8%$14.9M+13.4%$13.1M+9.1%$12.0M-52.5%$25.3M
Total Liabilities$48.9M-14.7%$57.3M-35.2%$88.4M-36.9%$140.2M+33.3%$105.2M+29.0%$81.5M+260.7%$22.6M+6.6%$21.2M-52.3%$44.4M-9.4%$49.0M+3.8%$47.3M+24.0%$38.1M-29.5%$54.0M+19.3%$45.3M+6.4%$42.5M
Current Liabilities$30.5M-11.6%$34.5M+3.7%$33.3M-14.6%$38.9M-19.2%$48.2M+4.6%$46.1M+153.0%$18.2M+9.0%$16.7M-14.5%$19.5M+6.1%$18.4M-0.6%$18.5M-41.6%$31.7M-27.3%$43.7M+14.0%$38.3M+10.6%$34.6M
Long-Term Debt$11.3M-38.7%$18.5M-57.8%$43.8M-50.1%$87.7M+74.1%$50.4M+67.6%$30.1M$0$0-100.0%$21.9M-9.6%$24.2M+12.4%$21.5M+540.7%$3.4M-32.1%$4.9M+41.3%$3.5M-30.0%$5.0M
Total Equity$173.2M+2.5%$169.0M+2.7%$164.6M+3.9%$158.5M+8.1%$146.6M+5.4%$139.2M+10.3%$126.2M-1.7%$128.3M+14.9%$111.7M+9.8%$101.7M+5.4%$96.5M+7.5%$89.8M+2.1%$88.0M+9.3%$80.5M-8.1%$87.6M
Retained Earnings$170.2M+3.3%$164.8M+2.9%$160.1M+2.3%$156.4M+6.7%$146.6M+17.1%$125.2M+11.9%$112.0M-1.7%$113.9M+14.0%$99.9M+9.0%$91.7M+7.3%$85.5M+9.9%$77.7M+12.1%$69.4M+10.2%$62.9M-11.8%$71.3M

ESCA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ESCA annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$28.7M$31.0M-14.0%$36.0M-25.4%$48.3M+463.6%$8.6M+698.4%$1.1M-59.2%$2.6M-83.6%$16.0M+146.5%$6.5M-51.3%$13.4M+9.8%$12.2M-21.3%$15.5M-19.9%$19.3M+114.2%$9.0M+47.3%$6.1M+136.9%$2.6M
Capital Expenditures$2.8M$2.5M+23.3%$2.0M-2.3%$2.1M-1.2%$2.1M-78.2%$9.7M+77.7%$5.5M+149.7%$2.2M-22.5%$2.8M+2.7%$2.7M+3.5%$2.7M-47.6%$5.1M+90.3%$2.7M+22.8%$2.2M+5.0%$2.1M-13.1%$2.4M
Free Cash Flow$25.9M$28.5M-16.2%$34.0M-26.5%$46.2M+615.4%$6.5M+175.0%-$8.6M-205.5%-$2.8M-120.4%$13.9M+275.6%$3.7M-65.3%$10.6M+11.6%$9.5M-8.5%$10.4M-37.5%$16.6M+143.2%$6.8M+68.9%$4.0M+1865.5%$206K
Investing Cash Flow-$5.1M-$4.8M-222.5%$3.9M+302.0%-$1.9M+94.9%-$37.8M-291.9%-$9.7M+54.1%-$21.0M-613.9%-$2.9M-111.8%$24.9M+693.6%-$4.2M+57.2%-$9.8M+31.4%-$14.3M-112.9%-$6.7M+28.1%-$9.3M-169.7%-$3.5M-355.9%$1.4M
Financing Cash Flow-$17.7M-$18.5M+48.3%-$35.8M+28.9%-$50.3M-274.5%$28.8M+205.3%$9.4M-41.0%$16.0M+259.7%-$10.0M+66.7%-$30.1M-249.7%-$8.6M-158.1%-$3.3M-38.0%-$2.4M+77.8%-$10.9M-3002.3%-$351K+90.8%-$3.8M-156.9%-$1.5M
Dividends Paid$8.3M$8.3M-0.3%$8.3M+34.4%$6.2M-24.2%$8.2M+6.0%$7.7M+3.0%$7.5M+3.6%$7.2M-0.2%$7.2M+9.2%$6.6M+5.2%$6.3M+3.5%$6.1M+14.7%$5.3M+14.5%$4.6M-8.9%$5.1M+58.0%$3.2M
Share Buybacks$2.2M$3.1M+41.2%$2.2M$0$0-100.0%$10.4M+54.8%$6.7M+129.4%$2.9M+29280.0%$10K$0$0N/AN/AN/A$0$0

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ESCA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ESCA annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin26.9%+2.2pp24.7%+1.3pp23.4%0.0pp23.5%-1.1pp24.6%-2.7pp27.3%+3.9pp23.5%-2.2pp25.6%+0.4pp25.2%-0.6pp25.8%-1.5pp27.3%-11.7pp39.0%-4.2pp43.2%-2.6pp45.8%+14.8pp31.1%
Operating Margin7.8%-0.2pp8.0%+1.2pp6.8%-1.6pp8.4%-1.8pp10.2%-1.9pp12.1%+6.9pp5.1%-2.7pp7.9%-0.4pp8.2%-0.3pp8.5%+0.5pp8.0%-1.7pp9.8%-0.1pp9.9%+1.7pp8.2%+5.1pp3.1%
Net Margin5.7%+0.5pp5.2%+1.4pp3.7%-2.0pp5.7%-2.0pp7.8%-1.7pp9.5%+5.5pp4.0%-7.6pp11.6%+3.7pp7.9%+1.2pp6.7%-0.6pp7.3%-0.2pp7.4%+1.4pp6.0%+9.3pp-3.3%-6.7pp3.3%
Return on Equity7.9%+0.2pp7.7%+1.7pp6.0%-5.4pp11.3%-5.3pp16.7%-2.0pp18.6%+12.9pp5.8%-10.2pp15.9%+3.3pp12.6%+1.3pp11.3%-0.7pp12.0%-1.1pp13.2%+2.0pp11.2%+17.3pp-6.1%-11.2pp5.1%
Return on Assets6.2%+0.4pp5.7%+1.9pp3.9%-2.1pp6.0%-3.7pp9.7%-2.1pp11.8%+6.9pp4.9%-8.8pp13.7%+4.7pp9.0%+1.4pp7.6%-0.4pp8.1%-1.2pp9.2%+2.3pp6.9%+10.8pp-3.9%-7.3pp3.4%
Current Ratio4.28+0.4x3.88-0.5x4.41-0.4x4.83+1.3x3.55+0.4x3.16-1.6x4.77-0.5x5.26+1.2x4.110.0x4.11+0.2x3.93+1.8x2.17+0.3x1.860.0x1.850.0x1.85
Debt-to-Equity0.070.0x0.11-0.2x0.27-0.3x0.55+0.2x0.34+0.1x0.22+0.2x0.000.0x0.00-0.2x0.200.0x0.240.0x0.22+0.2x0.040.0x0.060.0x0.040.0x0.06
FCF Margin11.9%-1.6pp13.5%-4.0pp17.5%+15.5pp2.1%+4.8pp-2.8%-1.7pp-1.0%-8.7pp7.7%+5.6pp2.1%-3.9pp6.0%+0.5pp5.5%-1.0pp6.5%-4.0pp10.5%+6.3pp4.2%+1.4pp2.7%+2.6pp0.1%

Similar Companies

Frequently Asked Questions

What is Escalade's annual revenue?

Escalade (ESCA) reported $240.2M in total revenue for fiscal year 2025. This represents a -4.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Escalade's revenue growing?

Escalade (ESCA) revenue declined by 4.5% year-over-year, from $251.5M to $240.2M in fiscal year 2025.

Is Escalade profitable?

Yes, Escalade (ESCA) reported a net income of $13.7M in fiscal year 2025, with a net profit margin of 5.7%.

Escalade (ESCA) reported diluted earnings per share of $0.99 for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Escalade (ESCA) had EBITDA of $23.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Escalade (ESCA) had $11.9M in cash and equivalents against $11.3M in long-term debt.

Escalade (ESCA) had a gross margin of 26.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Escalade (ESCA) had an operating margin of 7.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Escalade (ESCA) had a net profit margin of 5.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Escalade (ESCA) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Escalade (ESCA) generated $28.5M in free cash flow during fiscal year 2025. This represents a -16.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Escalade (ESCA) generated $31.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Escalade (ESCA) had $222.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Escalade (ESCA) invested $2.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Escalade (ESCA) invested $3.2M in research and development during fiscal year 2025.

Yes, Escalade (ESCA) spent $3.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Escalade (ESCA) had 14M shares outstanding as of fiscal year 2025.

Escalade (ESCA) had a current ratio of 4.28 as of fiscal year 2025, which is generally considered healthy.

Escalade (ESCA) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Escalade (ESCA) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Escalade (ESCA) has an Altman Z-Score of 6.54, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Escalade (ESCA) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Escalade (ESCA) has an earnings quality ratio of 2.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Escalade (ESCA) has an interest coverage ratio of 22.40x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Escalade (ESCA) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top